Is first- and second-line immunotherapy sequence the optimal strategy for unresectable hepatocellular carcinoma?. (March 2021) - Celsa, C.; Cabibbo, G.; Battaglia, S.; Enea, M.; Rizzo, G.E.M.; Busacca, A.; Stornello, C.; Giuffrida, P.; Craxì, A.; Cammà, C.